Etanercept

Lupin and Mylan Receive European Marketing Authorization for Nepexto®, Biosimilar Etanercept

Mumbai, June 04, 2020: Lupin Limited (Lupin) and Mylan N.V. (NASDAQ: MYL) today announced that the European Commission (EC) has…

4 years ago

Lupin and Yoshindo JV YL Biologics declares achievement worldwide stage.

New Delhi, February 08, 2018: YL Biologics declared that a worldwide stage III clinical trial of its investigational Etanercept biosimilar (YLB113) has…

6 years ago

Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home2/theprkho/public_html/thepharmatimes.in/wp-includes/functions.php on line 5420